Tokyo, Feb. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060631) titled 'Single Ingestion Study of Galactooligosaccharides' on Feb. 10.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Placebo
Primary Sponsor:
Institute - Yakult Honsha Co., Ltd.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To compare post-ingestion changes in blood glucose levels after single administration of glucose, OLIGOMATE 55N, and high-purity galactooligosaccharides in healthy adults.
Basic objectives2 - Efficacy
Intervention:
Inte...